SCYX Q1 2017 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$37M

Q1 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$64,000+0.0% YoY

Gross Profit

$64,000100.0% margin

Operating Income

-$6M-9400.0% margin

Net Income

-$5M-7607.8% margin

EPS (Diluted)

$-1.90

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$396,000

Balance Sheet

Total Assets

$57M

Total Liabilities

$23M

Stockholders' Equity

$34M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64,000	$64,000	+0.0%
Gross Profit	$64,000	$64,000	+0.0%
Operating Income	-$6M	-$7M	+16.6%
Net Income	-$5M	-$7M	+32.2%